Could less radiation be just as good for nasopharyngeal cancer?

NCT ID NCT07201337

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This phase 3 trial is testing whether giving a lower dose of radiation to low-risk areas around the main tumor works as well as the standard higher dose for nasopharyngeal cancer. The study plans to enroll 700 people aged 18-70 with newly diagnosed, non-spreading cancer. The goal is to see if the reduced dose can control the cancer just as well while causing fewer side effects and improving quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
radiation therapy
What this could lead to
If successful, this could allow doctors to use lower radiation doses for some patients, reducing long-term side effects while still controlling the cancer.
What could go wrong
This is a large phase 3 trial, but it's testing a non-inferiority approach—meaning the reduced dose might not be as effective as the standard. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NASOPHARYNGEAL CANCINOMA (NPC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Affiliated Cancer Hospital of Shantou University Medical College

    RECRUITING

    Shantou, Guangdong, China

  • Affiliated Hospital of Guangdong Medical University

    RECRUITING

    Zhanjiang, Guangdong, China

  • Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center

    RECRUITING

    Shenzhen, Guangdong, China

  • Dongguan People's Hospital

    RECRUITING

    Dongguan, Guangdong, China

  • Sun yat-sen university cancer center

    RECRUITING

    Guangzhou, Guangdong, 510060, China

  • The University of Hong Kong-Shenzhen Hospital

    RECRUITING

    Shenzhen, Guangdong, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.